What this means
This single-session, within-subject, sham-controlled early feasibility study evaluated the safety, tolerability, and feasibility of delivering 40 Hz audiovisual (gamma sensory) stimulation through a virtual reality (VR) headset in cognitively unimpaired older adults and in people with mild cognitive impairment (MCI) due to Alzheimer's disease or mild Alzheimer's disease.
A plain-English summary is on its way. Until then, this is the start of the registry's own summary.
- Status
- Completed
- Who can join
- Ages 50–90
- Where
- 2 sites, including California, Florida
The science
- Registered title
- The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation
- Trial ID
- NCT06234930 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Healthy Aging, Alzheimer's Disease, Mild Cognitive Impairment
- What is tested
- Audiovisual stimulation VR system
- Sponsor
- Clarity Health Technologies, Inc
- Ages
- 50 Years to 90 Years
- Dates
- First posted Jan 31, 2024 · updated Oct 26, 2026
Registry summary
This single-session, within-subject, sham-controlled early feasibility study evaluated the safety, tolerability, and feasibility of delivering 40 Hz audiovisual (gamma sensory) stimulation through a virtual reality (VR) headset in cognitively unimpaired older adults and in people with mild cognitive impairment (MCI) due to Alzheimer's disease or mild Alzheimer's disease.
Sites (2)
- The Sequoias Portola Valley, Portola Valley, California, United States
- Lakeview Institute of Clinical Research LLC, Leesburg, Florida, United States